US Stock MarketDetailed Quotes

RVMD Revolution Medicines

Watchlist
  • 44.120
  • +0.120+0.27%
Close Jan 3 16:00 ET
  • 44.120
  • 0.0000.00%
Post 16:20 ET
8.15BMarket Cap-12.05P/E (TTM)

Revolution Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revolution Medicines Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
EPS
-0.90
-0.94
-0.04
Miss Est.
+9.38%
+5.05%
-4.79%
Net Income
--
-156.29M
--
-44.13%
Analyst Rating
Strong Buy

Jan 4, 2025

Revolution Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 346.150K--
Nov 6, 20242024/Q30.000 / 346.150K--
Aug 7, 20242024/Q20.000 / 807.690K--
May 8, 20242024/Q10.000 / 674.200K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 346.150K--
Nov 6, 20242024/Q30.000 / 346.150K--
Aug 7, 20242024/Q20.000 / 807.690K--
May 8, 20242024/Q10.000 / 674.200K--

Unlock Free Earnings Estimates

Revolution Medicines Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:15 ET

  • 8-K: Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress

    Nov 6, 2024 16:07 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 7, 2024 16:18 ET

  • 8-K: Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress

    Aug 7, 2024 16:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 4, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data